Skip to main content
Clinical Trials/IRCT20190615043900N1
IRCT20190615043900N1
Completed
未知

Effectiveness of acupuncture treatment on chemotherapy induced peripheral neuropathy: a pilot randomized controlled trial

Beijing University of Chinese Medicine0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Chemotherapy-induced Peripheral Neuropathy.
Sponsor
Beijing University of Chinese Medicine
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • Patients with age between 18 and 70 years
  • Who have received neurotoxic chemotherapy (at least one complete course)
  • Have experienced symptoms of chemotherapy\-induced peripheral neuropathy for more than three months
  • Have scores \= 4 on 10 on the Numerical Rating Scale (NRS)
  • Accept and sign an informed consent form
  • Patients were also not to use medications such as Tricyclic antidepressants (TCA), calcium channel blockers, and membrane stabilizing drugs for the prevention or treatment of the neuropathy for at least one month before enrollment

Exclusion Criteria

  • History of disease that causes neuropathy, such as diabetes, multiple sclerosis, HIV, and Parkinson
  • The presence of peripheral neuropathy or history of peripheral neuropathy due to any cause excluding chemotherapy
  • Alcohol abuse
  • Psychological disease
  • Severe dysfunction of the heart, kidneys, or liver

Outcomes

Primary Outcomes

Not specified

Similar Trials